Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 27 min ago
Peer-reviewedCC BYMolecules (Basel, Switzerland)

Design, Synthesis, In Vitro and In Silico Evaluation of Triazole–Benzimidazole Hybrid Derivatives as Potential Inhibitors of EGFR, EGFR-L858R, and EGFR-L858R/T790M

  • Harun Uslu1
  • Arzu Hıdır2
  • Esra Yumuşak3
  • Derya Osmaniye2
  • Bünyamin Göktaş1
  • Yusuf Özkay2
  • Zafer Asım Kaplancıklı2
  1. 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Fırat University, 23119 Elazığ, Türkiye
  2. 2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Türkiye
  3. 3Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Türkiye
Read full textPDFCite

Related

  1. Synthesis, in silico study and cytotoxic evaluation of new benzimidazole derivatives as potential aromatase inhibitors
    Ayşen Işık, Nour El-Huda Daoud, Kezban Uçar Çiftçi +8
    Future Medicinal ChemistryPeer-reviewedLicence not statedFull textOrganic chemistryPMC
  2. Multistep synthesis of novel indole–benzimidazole hydrazone hybrids as xanthine oxidase inhibitors: In-Vitro evaluation, molecular docking, MD simulations and DFT studies
    Ammara, Abdul Latif, Mumtaz Ali +8
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOrganic chemistryCrossref
  3. Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel 1,2,4-Triazole-Functionalized Benzene-Sulfonate Derivatives as Potential Enzyme Inhibitors and Cytotoxicity in HepG2 Cells.
    Yasemin Ünver, Fikret Türkan, Halil İbrahim Güler +3
    Pharmaceuticals (Basel, Switzerland)Peer-reviewedCC BYFull textOrganic chemistryEurope PMC
  4. Synthesis and Evaluation of Aryloxy-Acetamide Derivatives as CBX2 Inhibitors
    Yuichiro Kawamoto, Shohei Takase, Ashutosh Kumar +4
    Chemical and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textOrganic chemistryJ-STAGE
  5. Stereochemical 2D NMR Assignment of Thietane, Synthesis and Antiplatelet Activity of Novel Thietane-Containing 1-Isobutylpurine-2,6-dione Derivatives as Potential GPIIb/IIIa Inhibitors
    Ferkat A. Khaliullin, Zhekshen K. Mamatov, Iuliia V. Shabalina +6
    Molecules (Basel, Switzerland)Peer-reviewedCC BYFull textOrganic chemistryEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{uslu2026design,
  title = {{Design, Synthesis, In Vitro and In Silico Evaluation of Triazole–Benzimidazole Hybrid Derivatives as Potential Inhibitors of EGFR, EGFR-L858R, and EGFR-L858R/T790M}},
  author = {Harun Uslu and Arzu Hıdır and Esra Yumuşak and Derya Osmaniye and Bünyamin Göktaş and Yusuf Özkay and Zafer Asım Kaplancıklı},
  journal = {Molecules (Basel, Switzerland)},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13666104},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Design, Synthesis, In Vitro and In Silico Evaluation of Triazole–Benzimidazole Hybrid Derivatives as Potential Inhibitors of EGFR, EGFR-L858R, and EGFR-L858R/T790M
AU  - Harun Uslu
AU  - Arzu Hıdır
AU  - Esra Yumuşak
AU  - Derya Osmaniye
AU  - Bünyamin Göktaş
AU  - Yusuf Özkay
AU  - Zafer Asım Kaplancıklı
PY  - 2026
DA  - 2026/09/27
JO  - Molecules (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13666104
SN  - 1420-3049
ER  -